NANOLEK

About NANOLEK

Nanolek, founded in 2011, is a prominent Russian pharmaceutical company focused on producing import-substituting medicines aimed at preventing and treating socially significant diseases. The company adheres to Good Manufacturing Practice (GMP) standards, ensuring high-quality production and stringent quality control for both medical and veterinary drugs. Additionally, Nanolek is ISO 9001 certified, emphasizing strong customer orientation, management involvement, a process approach, and continuous improvement.

Nanolek serves a diverse client base, including medical and pharmaceutical professionals, healthcare institutions, and government bodies. Operating within the Russian pharmaceutical market, the company has successfully transitioned to working with local suppliers and machine tool companies, aligning with the Russian government's import substitution initiative.

The business model of Nanolek revolves around the development, production, and distribution of high-quality pharmaceutical products. Revenue is primarily generated through the sale of these medicines to public and private healthcare sectors. The company has also been recognized for its dynamic growth, securing second place in the Dynamics of the Year category at the 24th Platinum Ounce competition.